Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-06

Clinical Trial Update: Evaluate the Efficacy and Safety of HMI-115 in Women With Moderate to Severe Endometriosis-associated Pain [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the efficacy and safety of HMI-115 for moderate to severe endometriosis-associated pain, with the study currently not yet re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HMI-115

Snippet

Sponsor: Hope Medicine (Nanjing) Co., Ltd | Conditions: Endometriosis | Phase 3 | Status: NOT_YET_RECRUITING